UTES vs. BBC
UTES (Virtus Reaves Utilities ETF) and BBC (Virtus LifeSci Biotech Clinical Trials ETF) are both exchange-traded funds - UTES is a Utilities Equities fund actively managed by Virtus Investment Partners, while BBC is a Health & Biotech Equities fund tracking the LifeSci Biotechnology Clinical Trials Index. UTES is actively managed, while BBC is passively managed. Over the past 10 years, UTES returned 12.40%/yr vs 7.64%/yr for BBC. At a 0.15 correlation, their price movements are largely independent. UTES charges 0.49%/yr vs 0.79%/yr for BBC.
Performance
UTES vs. BBC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, UTES achieves a 0.08% return, which is significantly lower than BBC's 8.64% return. Over the past 10 years, UTES has outperformed BBC with an annualized return of 12.40%, while BBC has yielded a comparatively lower 7.64% annualized return.
UTES
- 1D
- -0.98%
- 1M
- -6.58%
- YTD
- 0.08%
- 6M
- -1.81%
- 1Y
- 7.86%
- 3Y*
- 22.78%
- 5Y*
- 15.66%
- 10Y*
- 12.40%
BBC
- 1D
- 0.43%
- 1M
- -6.52%
- YTD
- 8.64%
- 6M
- 14.08%
- 1Y
- 116.78%
- 3Y*
- 19.99%
- 5Y*
- -1.96%
- 10Y*
- 7.64%
UTES vs. BBC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
UTES Virtus Reaves Utilities ETF | 0.08% | 25.71% | 45.35% | -2.46% | 0.80% | 20.74% | -0.30% | 25.48% | 5.14% | 14.21% |
BBC Virtus LifeSci Biotech Clinical Trials ETF | 8.64% | 63.77% | -1.11% | -1.80% | -35.13% | -22.31% | 30.32% | 63.81% | -18.29% | 57.85% |
Correlation
The correlation between UTES and BBC is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.25 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.24 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Sep 25, 2015 | 0.15 |
The correlation between UTES and BBC shifts across timeframes, from 0.15 (all time) to 0.25 (3 years), reflecting how their relationship changes across market environments.
UTES vs. BBC - Sectors Allocation Comparison
Sectors
UTES
BBC
Utilities
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Healthcare
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
UTES
BBC
-
Basic Materials
UTES
-
BBC
-
Communication Services
UTES
-
BBC
-
Consumer Cyclical
UTES
-
BBC
-
Consumer Defensive
UTES
-
BBC
-
Energy
UTES
-
BBC
-
Financial Services
UTES
-
BBC
-
Healthcare
UTES
-
BBC
Industrials
UTES
-
BBC
-
Real Estate
UTES
-
BBC
-
Technology
UTES
-
BBC
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
UTES vs. BBC — Risk / Return Rank
UTES
BBC
UTES vs. BBC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus Reaves Utilities ETF (UTES) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| UTES | BBC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.95 | ||
| Sortino ratioReturn per unit of downside risk | -3.33 | ||
| Omega ratioGain probability vs. loss probability | 1.08 | 1.46 | -0.38 |
| Calmar ratioReturn relative to maximum drawdown | 0.57 | 7.78 | -7.21 |
| Martin ratioReturn relative to average drawdown | 1.30 | 24.80 | -23.50 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| UTES | BBC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.37 | 3.32 | -2.95 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.76 | -0.05 | +0.81 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.62 | 0.20 | +0.41 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.70 | 0.12 | +0.58 |
Drawdowns
UTES vs. BBC - Drawdown Comparison
The maximum UTES drawdown since its inception was -35.39%, smaller than the maximum BBC drawdown of -76.85%. Use the drawdown chart below to compare losses from any high point for UTES and BBC.
Loading charts...
Drawdown Indicators
| UTES | BBC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -35.39% | -76.85% | +41.46% |
Max Drawdown (1Y)Largest decline over 1 year | -13.88% | -15.10% | +1.22% |
Max Drawdown (3Y)Largest decline over 3 years | -17.62% | -54.45% | +36.83% |
Max Drawdown (5Y)Largest decline over 5 years | -20.40% | -72.44% | +52.04% |
Max Drawdown (10Y)Largest decline over 10 years | -35.39% | -76.85% | +41.46% |
Current DrawdownCurrent decline from peak | -9.26% | -30.27% | +21.01% |
Average DrawdownAverage peak-to-trough decline | -5.52% | -37.14% | +31.62% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.08% | 4.73% | +1.35% |
Volatility
UTES vs. BBC - Volatility Comparison
The current volatility for Virtus Reaves Utilities ETF (UTES) is 7.40%, while Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a volatility of 10.93%. This indicates that UTES experiences smaller price fluctuations and is considered to be less risky than BBC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| UTES | BBC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.40% | 10.93% | -3.53% |
Volatility (6M)Calculated over the trailing 6-month period | 16.95% | 26.43% | -9.48% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.27% | 35.50% | -14.23% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.60% | 39.31% | -18.71% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.16% | 37.74% | -17.58% |
UTES vs. BBC - Expense Ratio Comparison
UTES has a 0.49% expense ratio, which is lower than BBC's 0.79% expense ratio.
Dividends
UTES vs. BBC - Dividend Comparison
UTES's dividend yield for the trailing twelve months is around 1.50%, less than BBC's 1.56% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 1.56% | 1.70% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.09% | 0.00% | 0.51% |
UTES Virtus Reaves Utilities ETF | 1.50% | 1.42% | 1.51% | 2.44% | 2.13% | 1.94% | 2.09% | 1.84% | 2.09% | 3.44% | 3.53% | 0.61% |
Frequently Asked Questions
UTES and BBC have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBC has higher volatility (10.93%) compared to UTES (7.40%). In terms of maximum drawdown, UTES dropped -35.39% vs BBC's -76.85%.
On 10-year performance, UTES leads with 12.40% vs 7.64% for BBC. On fees, UTES is cheaper at 0.49% per year. On volatility, UTES has been the lower-risk option at 7.40%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, UTES has performed better with a 12.40% return vs 7.64%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
UTES is cheaper with a 0.49% expense ratio, compared with 0.79% for BBC.
BBC has the higher dividend yield at 1.56%, compared with 1.50% for UTES.
UTES is categorized as Utilities Equities, while BBC is Health & Biotech Equities. Their fees differ too: 0.49% for UTES and 0.79% for BBC.
BBC currently has the higher Sharpe Ratio (3.32 vs 0.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for UTES and BBC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer